Belgian Law Seeks To Tackle Drug Shortages
Limits Risk Of ‘Excessive’ Sanctions For Suppliers
Belgium is to impose new reporting obligations on pharmaceutical companies that become aware of drug supply interruptions, in a move that is seen by suppliers as less draconian than measures taken in other European countries.
You may also be interested in...
Belgian body Medaxes is content with the latest pharmaceutical pricing legislation in the country, which cuts generics and biosimilars prices but also exempts such drugs from pharmaceutical clawback taxes.
As efforts continue to find ways of mitigating medicine shortages, a European survey has found not only that the situation is worsening, but that efforts to improve things are hindered by the patchwork of different rules on substitution and importation across the EU.
Belgium’s competition regulator has announced that it is investigating practices that have restricted or prevented biosimilars from entering the market.